Purpose: Long-term clinical usage of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with significant side effects -gastrointestinal lesions, bleeding and nephrotoxicity. Therefore, the discovery of new safer antiinflammatory drugs represents a challenging goal for this research area. (4d, e, h, j, k, q, p) 
INTRODUCTION
Non-steroidal anti-inflammatory agents (NSAIDS) continue to be one of the most widely used groups of therapeutic agents. They are used for the treatment of inflammation including pain, pyrexia and rheumatoid arthritis. With increasing life expectancy, it is not surprising that the development of newer NSAIDs continues at a rapid pace. Almost all the NSAIDs currently in clinical use are highly acidic in nature and suffer from the drawback of gastrointestinal toxicity [1] .
Indole alkaloids have proved to be medicinally important natural compounds. Indole ring constitutes an important template for drug design such as the classical NSAIDs indomethacin and indoxole. Furthermore, indole derivatives have been reported to possess promising biological activities including analgesic, anti-inflammatory [2] [3] [4] [5] , antihypertensive [6] , anticonvulsant [7] , antimicrobial [8] [9] and selective cyclooxygenase 2 COX 2 inhibitory activities [10] [11] [12] . Thus, efficient synthesis of novel substituted indole derivative compounds still represent highly pursued objective. The substitution of heterocyclic moiety at the 3-position of indole ring markedly influences anti-inflammatory activity [13] .
Design and synthesis of novel NSAIDs continues to be explored in order to achieve agents with better efficacy and safety profile. The diarylheterocycle class of compounds has been investigated extensively as COX 2 inhibitors. In contrast, relatively few reports document structural modifications of the existing NSAIDs into better drugs [14] . Thus, a major objective of this study was to explore the indole nucleus of indomethacin, an NSAID, for structural modification in order to produce potential antiinflammatory agents. Furthermore, since pyrimidine derivatives have also been reported to possess potent anti-inflammatory activity [15] [16] [17] , a second objective of this work, therefore, was to synthesize some indole derivatives possessing a pyrimidine moiety at 3-position of 2-phenyl indoles to obtain compounds (4a-4r) with superior biological activities.
EXPERIMENTAL Materials
All the reagents and solvents used in the synthesis work were of laboratory grade and procured from either SD Fine Chemicals, Qualigens or Sigma, India. All the solvents were dried and distilled before use. The animals used were procured from our institute's animal house.
Synthesis of 2-(4-substitutedphenyl) indole (1a-1c)
Synthesis of 2-(4-substitutedphenyl) indole (1a-1c) was carried out by the procedure of Fischer Indole synthesis [18] . p-Substituted acetophenone phenylhydrazone was prepared by warming a mixture of 0.04175 mole of acetophenone / p-methoxyacetophenone / p-chloroacetophenone and 0.04175 mole of phenyl hydrazine with 60 mLl of ethanol and few drops of glacial acetic acid. Filtered The reaction mixture was filtered, and the solid washed first with dilute HCl and then with 12 mL of cold rectified spirit. It was recrystallized with ethanol and 4 g of the crude phenylhydrazone was placed in a beaker containing 25.71 g of polyphosphoric acid The mixture was heated over a boiling water bath and maintained at 100 0 C for 10 min. Cold water (65 ml) was added, stirred well, filtered and washed well with water.
General procedure for the synthesis of 2-(4-substitutedphenyl) indole-3-carbaldhyde (2a-2c) 
General procedure for the synthesis of (E)-3-(2-(4-sunstitutedphenyl)-1H-indol-3-yl)-1-(4-sunstitutedphenyl)
prop-2-en-1-one (3a-3r) 
General procedure for the synthesis of 4-(4-substitutedphenyl)-6-(2-(4-substitutedphenyl)-1H-indol-3-yl) pyrimidin-2-amine (4a-4r)
Chalcones were cyclized with guanidine hydrochloride in the presence of sodium isopropoxide (synthesized in situ by adding sodium metal in isopropanol to give pyrimidines as follows:
To a solution of 1.1 moles of guanidine hydrochloride in 50 mL of isopropanol, 1.1 moles of sodium metal was added. The reaction mixture was refluxed for 2 h, chalcone (3a-3r, 1.0 equivalent) were added to it and then refluxed for 10 h. Solvent was removed from the reaction mixture under reduced pressure. Water (50 mL) was added and the aqueous phase extracted with 20 mL of ethyl acetate. The organic phase was dried over anhydrous Na 2 SO 4 , filtered and concentrated. The resulting product was recrystallized from ethanol, and their melting point, % yield and molecular formula are given in Table 1 
Characterization of synthesized compounds
Melting point was determined in an open capillary on Veego electronic apparatus (model:-VMP-D) and are uncorrected. Infrared IR spectra of the synthesized compounds were recorded on Shimadzu 8400-S FT-IR spectrophotometer using potassium bromide while 1 H NMR spectra were recorded in DMSO-d 6 using NMR Varian-Mercury 300 MHz spectrometer and chemical shifts are reported as parts per million (ppm) using tetramethylsilane (TMS) as an internal standard. Carbon, hydrogen and nitrogen (C, H and N, respective) analyses were carried out on a CE Instruments EA 1110 analyzer. To monitor the reactions and establish the identity and purity of reactants and products, thin layer chromatography (TLC) was performed on microscopic glass slides (2 x 7.5 cm) coated with silica gel-G (Merck), using toluenemethanol and chloroform-methanol as the solvent systems; the spots were visualized by exposure to iodine vapors, dilute sulfuric acid spray or ultraviolet (UV).
Animals
Wistar rats (150 -200 g) and albino mice (25 -30 g) of either sex were selected for the experiments. The animals were acclimatized for a period of two weeks in our laboratory environment prior to the study. They were housed in polypropylene cages, maintained under standard laboratory conditions, andfed with standard diet and water ad libitum. were followed throughout the experiment.
Assessment of anti-inflammatory activity
Anti-inflammatory activity was evaluated using carrageenan-induced rat paw edema model [19] . Wistar rats (150 -200 g) were divided into groups of six animals each. Group 1 served as control group and received saline, group 2 received indomethacin (10 mg/kg) and other groups received test drugs in a dose of 20 mg/kg. The drugs were prepared as homogenous suspensions in saline (0.9 % NaCl) and administered orally to animals. One hour after drug administration, each rat received a sun planter injection of 0.1 ml of 1 % carrageenan solution in its left paw. Measurement of the hind paw volume was carried out using a plethysmometer prior to treatment (Vo), and 2 and 3 h (Vt) after drug administration. Inhibition of swelling by the drugs was calculated using Eq 1.
Inhibition (%) = {[(Vt-Vo) control-(Vt-Vo) treated]/ (Vt-Vo) control} x100 …….…… (1) where Vt and Vo relates to the mean volume of the hind paw of the rats (n=6) before and after anti-inflammatory agent treatment, respectively. The results are shown in Table  2 .
Analgesic activity
All the compounds were tested for analgesic activity, using the acetic acid induced writhing method [20] in albino mice (25 -30 g) of either sex. A 0.6 % v/v solution of acetic acid was used as writhing-inducing agent. The test compounds and indomethacin were administered orally 1 h prior to acetic acid injection. The mice were divided into groups of six animals each. Group 1 served as control group and received saline, group 2 received indomethacin (10 mg/kg) while the other groups received test drugs in a dose of 20 mg/kg. The drugs were prepared as homogenous suspensions in saline (0.9 % NaCl) and administered orally to the animals. The writhing-inducing agent was administered intraperitonially. The number of writhings within a period of 20 min after drug administration was counted for each of the animal groups. Protection was calculated using Eq 2. Protection (%) = 100(100 -W1)./ W1 ……….. (2) where W 1 is the number of writhins of test group and W 2 is the number of writhings in the control group. The results are expressed as % decrease in writhing with respect to control and presented in Table 3 .
Evaluation of acute ulcerogenesis
The studies were carried out using healthy Wistar rats (150 -200 g) at thrice the dose (60 mg/kg) given in the anti-inflammatory studies. [21] . The animals were divided into different groups of six animals each. Group 1 served as control and received vehicle (1% aqueous methylcellulose dispersion) only, group 2 received the standard drug (indomethacin, 60 mg/kg) while the other groups were administered test compounds in doses molecularly equivalent to 60 mg/kg of indomethacin. The animals were fasted 6 h prior to receiving a single dose of either vehicle, standard or test compound. Following drug treatment, the rats were fed normal diet and then sacrificed after chloroform anaesthesia 14 h later.. The gastric mucosa of the rats was examined with the aid of a magnifier. For each stomach, the severity of mucosal damage was assessed according to the following scoring system: 0 = ≤ 5 punctiform lesions; 1 = > 5 punctiform lesions; 2 = one to five small ulcers; 3 = more than five small ulcers of one large ulcer; 4 = more than one large ulcer. The mean score of each treated group minus the mean score of the control group was taken as the 'severity index' of gastric damage (p < 0.001).
The data are shown in Table 4 . 
Statistical analysis
The data were analysed by one-way ANOVA followed by Dunnet's t-test using computerized GraphPad Prism software, version 5. All the results are expressed as mean ± SEM. P values < 0.01 were considered significant.
Anti-inflammatory activity
The inhibition of swelling in carrageenaninduced edema in rat paw brought about by oral administration of the drug is shown in Table 2 .
All the synthesized compounds tested for anti-inflammatory activity showed inhibition of edema ranging from 54.8 to 88.2 %, especially compounds 4d, e, j, k, q and p which demonstrated very good antiinflammatory activity. In particular, 4-(2-amino-6-(2-(4-chlorophenyl)-1H-indol-3-yl)pyrimidin-4-yl)phenol (4j, 87.4 %) and 4-(4-aminophenyl)-6-(2-(4-chlorophenyl)-1H-indol-3-yl)pyrimidin-2-amine (4k, 88.2 %) were equipotent with indomethacin (92.7%) in inhibiting paw edema.
RESULTS

Analgesic activity
Compounds (4a -4r) were tested for analgesic activity at the same dose as for antiinflammatory activity. Analgesic activity, measured by % protection against writhing in mice afforded by the drugs, is shown in Table  3 . The compounds tested showed analgesic activity in the range of 44.5 to 82.3 %. Compounds 4h and 4q were especially potent showing 82.3 and 79.4 % protection, respectively, against acetic acid-induced writhing which compares well with 82.8 % for indomethacin. The analgesic effects of the compounds were in a similar way to their anti-inflammatory effects.
Acute ulcerogenesis
Ulcerogenic effect was studied at 60 mg/kg in rats (thrice the dose used in the earlier tests) and the data are shown in Table 4 . The ulcerogenic effect, measured by severity index, of compounds 4a -4r (0.88 to 1.96) was appreciably less than that of indomethacin (2.16). Ulcerogenic effect was especially low for compounds 4d, 4g, 4h 4j and 4p with severity index of 0.94, 0.88, 0.89, 0.89 and 0.98, respectively.
DISCUSSION
The purpose of the present study was to examine whether molecular modification of indole and pyrimidine would result in molecules with good analgesic/antiinflammatory actions and less ulcerogenic effects. A series of compounds was synthesized and evaluated for biological activities. The data obtained indicate that compounds having indole nucleus with substituted phenyl ring at 2-position and substituted pyrimidine ring at 3-position are not only good analgesic and antiinflammatory agents but exhibited less ulcerogenic effect. Pyrimidines having substituted phenyl ring at 6 th position were in general more active than unsubstituted ones, indicating that the presence of functional group may be helpful in orienting the molecule in active site. Pyrimidines having hydroxyl and amino group substituted at para position of phenyl ring at position-6 were found to be more active than others, indicating that the presence of groups forming hydrogen bonds may aid more efficient binding with the receptors. The presence of an electronegative group at para position of 2-phenyl ring on indole nucleus seems to be important for good antiinflammatory action. These findings suggest that the newly synthesized compounds will produce less gastric irritation and may be considered as safer drugs for treating inflammatory conditions. Compounds with 4-chlorophenyl and 4-aminophenyl rings at 6 th position of the pyrimidine ring showed higher analgesic activity than other substitutions.
CONCLUSION
Various derivatives of 3-(2-aminopyrimidin-4-yl) indoles were successfully synthesized and screened for their analgesic, antiinflammatory and ulcerogenic activities. The tested compounds showed comparable analgesic and anti-inflammatory activities with indomethacin but were less irritant to the gastric mucosa. The results obtained support our hypothesis that chemical hybridization of indole nucleus and pyrimidine ring at the appropriate position affords compounds with good analgesic and antiinflammatory activities, and less gastric irritation. Further studies are planned to include in vitro COX 2 assay as well as elucidation of quantitative structure-activity relationship, leading to the derivation of a pertinent equation.
